CompuGROUP stalls offer for iSoft:
This article was originally published in Clinica
CompuGROUP (Koblenz, Germany) has announced it will not increase its offer for iSoft, a move which leaves Australian firm IBA Health as the frontrunner to buy the UK medical software supplier. IBA's offer of 69p per share trumped CompuGROUP's bid of 66p per share (see Clinica No 1270, p 13).
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.